Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., . . . Morton, J. P. (2016). CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. Cancer cell, 29(6), 832. https://doi.org/10.1016/j.ccell.2016.04.014
Citácia podle Chicago (17th ed.)Steele, Colin W., et al. "CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma." Cancer Cell 29, no. 6 (2016): 832. https://doi.org/10.1016/j.ccell.2016.04.014.
Citácia podľa MLA (8th ed.)Steele, Colin W., et al. "CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma." Cancer Cell, vol. 29, no. 6, 2016, p. 832, https://doi.org/10.1016/j.ccell.2016.04.014.